Pfizer Limited has submitted a certificate confirming compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. The certificate was issued by KFin Technologies Limited, the company's Registrar & Share Transfer Agent, on January 7, 2026.

KFin Technologies Limited confirmed that securities received from depository participants for dematerialisation during the quarter ended December 31, 2025, were processed in compliance with the regulations. The securities were confirmed, accepted, or rejected by KFin Technologies and listed on the stock exchanges where they are already listed. Furthermore, the security certificates received for dematerialisation were mutilated and cancelled after verification by the depository participant, and the depositories' names were substituted in the register of members as the registered owner within the stipulated 30 days.

The company has requested the stock exchanges, BSE Limited and the National Stock Exchange of India Ltd., to take this confirmation on record.